Comparison of 5-year treatment result of laser photocoagulation and intravitreal injection of bevacizumab for retinopathy of prematurity

Comparison of 5-year treatment result of laser photocoagulation and intravitreal injection of bevacizumab for retinopathy of prematurity - Treatment result of intravitreal injection of bevacizumab for retinopathy of prematurity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041469

Enrollment

Registered

2020-08-21

Start date

2020-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of prematurity

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent laser photocoagulation or intravitreal injection of bevacizumab for retinopathy of prematurity.

Exclusion criteria

Exclusion criteria: Patients who did not have at least 5 years of follow-up.

Design outcomes

Primary

Measure	Time frame
Visual acuity at the age of 5	—

Secondary

Measure	Time frame
Equivalent spherical value, ocular complications and mental retardation at the age of 5	—

Countries

Japan

Contacts

Public ContactTomoya Murakami

University of Tsukuba Department of ophthalmology

murakami-tuk@umin.ac.jp029-853-3148

Outcome results